Quotient Clinical
Who owns Quotient Clinical?
Quotient Clinical is a British Pharma company, currently owned by GHO Capital since 2015. It changed hands in 2015, when Bridgepoint sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods
Bridgepoint sold Quotient Clinical to GHO Capital in 2015 after 2 years.
More from GHO Capital Fund I LP
Other portfolio companies in the same fund.
US· 2018
Germany· 2018
UK· 2016US· 2015UK· 2015More PE-backed in Pharma
Comparable pharma deals from other GPs.
France
SpainQuestions
Who owns Quotient Clinical?
Quotient Clinical is currently owned by GHO Capital, through GHO Capital Fund I LP, since 2015.
When did GHO Capital acquire Quotient Clinical?
GHO Capital acquired Quotient Clinical in 2015.
Who did Quotient Clinical sell to?
Bridgepoint sold Quotient Clinical to GHO Capital in 2015 (Secondary).
Who has owned Quotient Clinical over time?
Quotient Clinical has been through 2 private-equity ownership periods: Bridgepoint · via Europe VII (BE VII) · 2013–2015 · sold to GHO Capital · (Secondary); GHO Capital · via GHO Capital Fund I LP · since 2015.